vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2025

Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Symbol
VTVT on Nasdaq
Shares outstanding
4,080,222
Price per share
$40.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
988,279
Total reported value
$23,052,921
% of total 13F portfolios
0%
Share change
+401,136
Value change
+$9,364,357
Number of holders
23
Price from insider filings
$40.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Samsara BioCapital, L.P. 9.9% 0% $12,001,117 +$1,803,961 403,942 +18% Srinivas Akkaraju 08 Dec 2025
Invus Global Management, LLC 9.4% -5.9% $9,179,310 +$1,051,154 393,098 +13% Raymond Debbane 30 Sep 2025
Trails Edge Capital Partners, LP 9.9% $5,108,040 340,536 Trails Edge Capital Partners, LP 29 Aug 2025

As of 30 Sep 2025, 23 institutional investors reported holding 988,279 shares of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT). This represents 24% of the company’s total 4,080,222 outstanding shares.

Top 24 Institutional Shareholders

The largest institutional shareholders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) together control 24% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SAMSARA BIOCAPITAL, LLC 9.2% 374,461 +81% 1.1% $8,743,664
FMR LLC 4.7% 192,891 +8.2% 0% $4,487,609
Siren, L.L.C. 4% 163,000 0.15% $3,806,050
BAKER BROS. ADVISORS LP 3.6% 148,314 +52% 0.03% $3,463,132
VANGUARD GROUP INC 1.2% 46,990 +8.8% 0% $1,093,223
GEODE CAPITAL MANAGEMENT, LLC 0.37% 15,298 +19% 0% $355,962
NORTHERN TRUST CORP 0.34% 14,072 -7.9% 0% $328,581
MILLENNIUM MANAGEMENT LLC 0.32% 12,935 -14% 0% $300,933
Connective Capital Management, LLC 0.24% 9,712 0% 0.21% $226,775
BlackRock, Inc. 0.12% 4,935 +2.2% 0% $115,233
UBS Group AG 0.07% 2,970 +4.3% 0% $69,350
OSAIC HOLDINGS, INC. 0.04% 1,620 +853% 0% $37,169
MORGAN STANLEY 0.02% 746 0% 0% $17,419
Strengthening Families & Communities, LLC 0% 173 0% $4,039
Activest Wealth Management 0% 50 0% 0% $1,168
CoreCap Advisors, LLC 0% 45 0% 0% $1,051
Parallel Advisors, LLC 0% 38 0% 0% $887
Sunbelt Securities, Inc. 0% 15 0% 0% $350
BNP PARIBAS FINANCIAL MARKETS 0% 9 0% 0% $210
SBI Securities Co., Ltd. 0% 2 0% 0% $47
Strategic Wealth Partners, Ltd. 0% 1 0% 0% $23
BANK OF AMERICA CORP /DE/ 0% 1 -92% 0% $23
CITIGROUP INC 0% 1 0% $23
RAYMOND JAMES FINANCIAL INC 0% 0 -100% $0

Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 45 $1,800 $40.00 1
2025 Q3 988,279 $23,052,921 +$9,364,357 $23.35 23
2025 Q2 587,143 $8,742,344 +$226,154 $15.00 21
2025 Q1 571,712 $9,902,095 +$353,201 $17.32 20
2024 Q4 551,416 $7,570,090 +$133,643 $13.81 17
2024 Q3 542,324 $7,337,088 +$2,516,893 $13.56 20
2024 Q2 348,140 $6,148,038 +$252,272 $17.66 19
2024 Q1 333,650 $7,850,341 +$6,240,904 $23.53 19
2023 Q4 68,620 $788,715 +$781,835 $11.50 14
2023 Q3 600 $287 +$287 $0.48 1